In general, healthy ECs and tumor-derived ECs were positive for all tested markers except for CD34 (VWF+, ACE+, CD31+, CD133+, CD105+), but pathological ECs were characterized by lower levels of expression (Figure 2). The gene discussed is CD34; the disease is neoplasm.